Liberase is one of 2 small molecule programs targeting Frailty. It is currently in Preclinical.
Indications
Total Trials
Active Trials
Competitors
Pipeline
Competition
2 competitors in Frailty
Mitoquinone Mesylate
Liberase
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Sources
Details